Basilea Pharmaceutica Ltd. announced that it has appointed David Veitch as Chief Commercial Officer of the company. Mr. Veitch will join the company on September 1, 2014. As a member of the management committee, he will be responsible for leading the company's commercial operations including sales, marketing, pricing and market access, reporting to Chief Executive Officer Ronal Scott.

Most recently he was President European Operations at Savient Pharmaceuticals.